Alzheon’s amyloid-targeting pill fails another Alzheimer’s Phase 3

Alzheon’s controversial, decade-long bet that a failed Alzheimer’s drug could offer bigger benefits to a subset of patients at the highest risk for the disease has ended in another disappointment. On Thursday, the Framingham, MA ...

Apr 10, 2025 - 15:40

Alzheon’s amyloid-targeting pill fails another Alzheimer’s Phase 3

Alzheon’s controversial, decade-long bet that a failed Alzheimer’s drug could offer bigger benefits to a subset of patients at the highest risk for the disease has ended in another disappointment. On Thursday, the Framingham, MA ...